Correlation Ventures Invests in Five New Portfolio Companies in Q2
July 3, 2013
Correlation Ventures, the venture capital industry’s predictive analytics pioneer, announces five new portfolio company additions in the second quarter of 2013, with the total number of new portfolio companies added in 2013 to 13. These new portfolio company additions bring Correlation Ventures’ portfolio to 52 companies in a diverse set of industries including SaaS, semiconductors, consumer and business services, energy, medical devices, healthcare services, and biopharmaceuticals.
During Q2, Correlation demonstrated its continuing commitment to investing in the most promising U.S. headquartered startups regardless of sector, stage, or geography. Correlation made initial investments in Outbox, Proximal Data and three seed-stage companies. Co-investors in these new portfolio companies included Avalon Ventures, Divergent Ventures, DN Capital, First Round Capital, Founders Fund, Google Ventures, Innovation Endeavors, Khosla Ventures, Kleiner Perkins, and SoftTech VC.
"We are gratified that the U.S. venture ecosystem -- including leading VC firms and world-class entrepreneurs -- has responded so enthusiastically to our value proposition, including our guarantee of a decision in 2 weeks or less with no incremental hassle to the management team or VCs in the syndicate," said Trevor Kienzle, Managing Director of Correlation Ventures. "Our entire firm is focused on continuing to meet this value proposition every time.”
ABOUT CORRELATION VENTURES
Correlation Ventures, a $165 million venture capital fund, leverages world-class analytics to offer entrepreneurs and other venture capitalists a dramatically better option when they are seeking additional co-investment capital to complete a financing round. The firm makes investment decisions in two weeks or less and offers reliability and transparency about reserves and its intentions to follow in future financings. Correlation Ventures invests across all industry segments, U.S. geographies and investment stages – from seed through late stage. The fund's current portfolio includes companies such as AirXpanders, Aldea Pharmaceuticals, Bunchball, CareWell Urgent Care, Crossbar, edo interactive, Framehawk, MOGL, Retrofit, RQx Pharmaceuticals, SAY Media, Telly and Urjanet. Correlation Ventures has offices in Palo Alto and San Diego, CA. For more information, visit http://www.correlationvc.com and @correlationvc.